203 related articles for article (PubMed ID: 27581750)
21. A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia.
Kerrigan V; Kelly A; Lee AM; Mungatopi V; Mitchell AG; Wyber R; Ralph AP
BMC Health Serv Res; 2021 Oct; 21(1):1127. PubMed ID: 34670567
[TBL] [Abstract][Full Text] [Related]
22. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
[TBL] [Abstract][Full Text] [Related]
23. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
[TBL] [Abstract][Full Text] [Related]
24. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community.
Eissa S; Lee R; Binns P; Garstone G; McDonald M
Aust N Z J Public Health; 2005 Dec; 29(6):521-5. PubMed ID: 16366062
[TBL] [Abstract][Full Text] [Related]
25. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia.
Rémond MG; Severin KL; Hodder Y; Martin J; Nelson C; Atkinson D; Maguire GP
Intern Med J; 2013 Apr; 43(4):386-93. PubMed ID: 22646671
[TBL] [Abstract][Full Text] [Related]
26. Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011.
Rémond MG; Wheaton GR; Walsh WF; Prior DL; Maguire GP
Heart Lung Circ; 2012 Oct; 21(10):632-8. PubMed ID: 22726405
[TBL] [Abstract][Full Text] [Related]
27. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.
Ralph AP; Noonan S; Wade V; Currie BJ
Med J Aust; 2021 Mar; 214(5):220-227. PubMed ID: 33190309
[TBL] [Abstract][Full Text] [Related]
28. "Hurts less, lasts longer"; a qualitative study on experiences of young people receiving high-dose subcutaneous injections of benzathine penicillin G to prevent rheumatic heart disease in New Zealand.
Cooper J; Enkel SL; Moodley D; Dobinson H; Andersen E; Kado JH; Barr RK; Salman S; Baker MG; Carapetis JR; Manning L; Anderson A; Bennett J
PLoS One; 2024; 19(5):e0302493. PubMed ID: 38743745
[TBL] [Abstract][Full Text] [Related]
29. Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Establishment of a prophylactic program.
Neilson G; Streatfield RW; West M; Johnson S; Glavin W; Baird S
Med J Aust; 1993 Mar; 158(5):316-8. PubMed ID: 8474371
[TBL] [Abstract][Full Text] [Related]
30. Lessons to be learned: Using National Immunisation strategies to improve adherence to acute rheumatic fever secondary prophylaxis.
Liaw JY; White AV; Gorton S; Axford-Haines L
J Paediatr Child Health; 2019 Oct; 55(10):1170-1176. PubMed ID: 31410921
[TBL] [Abstract][Full Text] [Related]
31. Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.
Barr RK; Barber BW; Tait JR; Landersdorfer CB; Salman S; Musk GC; Page-Sharp M; Batty KT; Kado J; Manning L; Carapetis JR; Boyd BJ
Eur J Pharm Biopharm; 2023 Aug; 189():240-250. PubMed ID: 37354997
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks.
Lue HC; Wu MH; Wang JK; Wu FF; Wu YN
J Pediatr; 1994 Nov; 125(5 Pt 1):812-6. PubMed ID: 7965439
[TBL] [Abstract][Full Text] [Related]
33. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
[TBL] [Abstract][Full Text] [Related]
34. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
Liaw J; Gorton S; Heal C; White A
Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
[TBL] [Abstract][Full Text] [Related]
35. Mismatches between health service delivery and community expectations in the provision of secondary prophylaxis for rheumatic fever in New Zealand.
Anderson A; Peat B; Ryland J; Ofanoa M; Burgess H; Malungahu G; Wade J; Spray J; Leversha A
Aust N Z J Public Health; 2019 Jun; 43(3):294-299. PubMed ID: 30908804
[TBL] [Abstract][Full Text] [Related]
36. Rheumatic fever prophylaxis in South Africa--is bicillin 1,2 million units every 4 weeks appropriate?
Daniels ED; Mohanlal D; Pettifor JM
S Afr Med J; 1994 Aug; 84(8 Pt 1):477-81. PubMed ID: 7825080
[TBL] [Abstract][Full Text] [Related]
37. Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review.
Kevat PM; Reeves BM; Ruben AR; Gunnarsson R
Curr Cardiol Rev; 2017; 13(2):155-166. PubMed ID: 28093988
[TBL] [Abstract][Full Text] [Related]
38. Ending rheumatic heart disease in Australia: the evidence for a new approach.
Wyber R; Noonan K; Halkon C; Enkel S; Cannon J; Haynes E; Mitchell AG; Bessarab DC; Katzenellenbogen JM; Bond-Smith D; Seth R; D'Antoine H; Ralph AP; Bowen AC; Brown A; Carapetis JR;
Med J Aust; 2020 Nov; 213 Suppl 10():S3-S31. PubMed ID: 33190287
[TBL] [Abstract][Full Text] [Related]
39. Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14-21 in New Zealand: a framework method study.
Barker H; Oetzel JG; Scott N; Morley M; Carr PEA; Oetzel KB
Int J Equity Health; 2017 Nov; 16(1):201. PubMed ID: 29149897
[TBL] [Abstract][Full Text] [Related]
40. [5 years of recurrence prevention of rheumatic fever using benzathine penicillin].
Menner K
Med Welt; 1967 Nov; 45():2723-5. PubMed ID: 5609215
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
